ADAA members receive a complimentary annual online subscription to Depression and Anxiety. Per the ISI Journal Citation Reports Rankings for 2016, the Depression and Anxiety impact factor is 4.971. The Journal ranks 19 of 142 in psychiatry journals; 8 of 77 in psychology journals; 7 of 121 for psychology clinical journals, and 15 of 139 for psychiatry social science journals. Google Scholar psychiatry journal ranking (spring 2017) ranked Depression and Anxiety #19 of 20.
Depression and Anxiety, the official online journal of the Anxiety and Depression Association of America welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans.
A priority is placed on papers focusing on treatment, as well as those providing cutting-edge reviews of key areas and issues, in order to enhance the clinical evaluation and care of individuals struggling with the effects of these disorders. All submissions are peer-reviewed; there is no handling or publishing fee. Meet the Journal Editorial Board.
- You must be a current member to log in. Download member log-in instructions here.
- If you have questions about your login, please contact ADAA Membership.
Interested in submitting an article? View our Journal Submissions Guidelines.
December 2017 Issue - Volume 34, Issue 12
Treatment of Depression and Anxiety: Sweating the Small Stuff
Individuation for a DSM-5 disorder: Adult separation anxiety (pages 1082–1084)
Jeffrey R. Strawn and Eric T. Dobson
Version of Record online: 6 DEC 2017 | DOI: 10.1002/da.22703
A randomized controlled pilot trial of vilazodone for adult separation anxiety disorder (pages 1085–1095)
Franklin R. Schneier, Danielle M. Moskow, Tse-Hwei Choo, Hanga Galfalvy, Raphael Campeas and Arturo Sanchez-Lacay
Version of Record online: 25 OCT 2017 | DOI: 10.1002/da.22693
Ultra-brief behavioral skills trainings for blood injection injury phobia (pages 1096–1105)
Alicia E. Meuret, Erica Simon, Lavanya Bhaskara and Thomas Ritz
Version of Record online: 15 MAR 2017 | DOI: 10.1002/da.22616
A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills (pages 1147–1156)
Nicholas J. Carson, Ana M. Progovac, Ye Wang and Benjamin L. Cook
Version of Record online: 29 SEP 2017 | DOI: 10.1002/da.22681
ADAA Journal in the News
A Common Medication Given to New Moms Has Been Linked to Postpartum Depression published in GoodHousekeeping (February 10, 2017). Covers "Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year" study by Aimee R. Kroll-Desrosiers MS, Benjamin C. Nephew PhD, Jessica A. Babb PhD, Yurima Guilarte-Walker MS, Tiffany A. Moore Simas MD, MPH, MEd, Kristina M. Deligiannidis MD.
Please note: Three open-access journals, the Journal of Depression & Anxiety (OMICS); Anxiety and Depression Research (Herbert Publications); and Annals of Depression and Anxiety (Austin Publishing) are not affiliated with ADAA. These publishers require payment of a handling or submissions fee from authors; find information about these fees on their websites. These publications are not related to Depression and Anxiety, the official ADAA journal.